Mergers posts
FeedPosted Oct 15th 2009 11:00AM by Tom Johansmeyer (RSS feed)
Filed under: Private equity, Blackstone Group L.P (BX), Initial public offerings, Recession
Up until the credit crisis, private equity firms had it made. They had plenty of leverage to play with and could load up their acquisition targets with it. So, they could realize a fantastic return on equity, mitigate their own risks, and show that they were the studs of the Street.
Then, all that went away. Credit markets dried up, and private equity companies lost their acquisition fuel. The numbers aren't as big as they used to be, but it looks like the private equity market is back in action.
Continue reading Private equity biz back in action
Posted Sep 30th 2009 8:20AM by Michael Fowlkes (RSS feed)
Filed under: Major movement, International markets, Earnings reports, Deals, Good news, Press releases, Time Warner (TWX), Pfizer (PFE), Market matters, Walgreen Co (WAG), Whole Foods Market (WFMI), Xerox Corp (XRX), Staples Inc (SPLS), American Eagle Outfitters (AEO)

All three of the major indexes finished Tuesday in the red, but there were several big names that moved up to new 52-week highs in Tuesday's trading.
Walgreen Co. (NYSE:
WAG): The drugstore giant had a really good day on Wall Street after posting
better than expected earnings in the morning before the market opened. The company posted earnings of 44 cents per share versus analyst estimates of 39 cents. The stock set a new 52-week high of $38.44 and closed the day up 9.2% at $37.35.
Continue reading Some big names set new 52-week highs Tuesday: WAG, ACS, WYE ...
Posted Sep 22nd 2009 12:50PM by Tom Taulli (RSS feed)
Filed under: Google (GOOG), Microsoft (MSFT), Yahoo! (YHOO), Private equity, Small business
Since coming on board Yahoo! (NASDAQ: YHOO) early this year, Carol Bartz has wasted little time in making changes. Part of the strategy is to get the company more focused.
So, it looks like Yahoo! is in the process of selling its small business unit. All in all, it's a good asset, with web hosting, domain name services, and merchant accounts. The deal may also include the HotJobs division.
Continue reading Yahoo! seeks to unload small biz assets
Posted Sep 9th 2009 2:50PM by Tom Taulli (RSS feed)
Filed under: PetroChina Co Ltd ADR (PTR)
As the dollars keep piling up in China, there is a need to put the money to work. So how about oil? No doubt, China needs this vital commodity as its economy continues to grow at a rapid clip. Consider that the country imports roughly 3.6 million barrels of oil a day -- and this will inevitably increase in the coming years.
To gear up for things, China National Petroleum Corp. (CNPC) -- which is the parent company of PetroChina (NYSE: PTR) -- secured a $30 billion loan from the Chinese government. Apparently, the interest rate was fairly low (the loan term is five years). And, yes the money will be used to buy up energy assets across the globe.
Continue reading PetroChina's sugar daddy gets $30 billion for takeovers
Posted Jun 26th 2009 11:00AM by Tom Johansmeyer (RSS feed)
Filed under: Pfizer (PFE), JPMorgan Chase (JPM), Goldman Sachs Group (GS), Morgan Stanley (MS)
Mergers and acquisitions aren't delivering the fees that investment bankers used to enjoy, but fortunately, the money's coming from elsewhere. Data from Thomson Reuters reports a 29% increase in capital markets and M&A fees for the first time in more than a year. Share sales (e.g., rights offerings) were where dealmakers found the action. In the shrinking M&A space, Morgan Stanley (NYSE: MS) has taken the lead spot.
Since there are fewer banks in the marketplace than there were a year ago -- and they have less money -- the capital is starting to come from elsewhere. Because they aren't lending at their previous pace, companies are issuing bonds and equity to replenish their coffers. Pfizer (NYSE: PFE), for example, raked in more than $23 billion from the bond market to fund its acquisition of Wyeth (NYSE: WYE), and Roche nabbed Genentech with the help of a $30 billion debt issuance.
Continue reading M&A plunges, investment banks find money elsewhere
Posted Apr 20th 2009 12:40PM by Beth Gaston Moon (RSS feed)
Filed under: Earnings reports, Deals, Coca-Cola (KO), PepsiCo (PEP)
We're in the heat of earnings season, with many of the top 100 S&P 500 companies reporting this week. One name that slightly fizzled at its earnings report today was PepsiCo Inc. (NYSE: PEP), which announced first-quarter net results of $1.14 billion, or 72 cents per share, a 0.9% decline from previous year's levels.
On the plus side, the per-share result was a nickel better than analysts were expecting, according to Thomson Reuters. Revenue, on the other hand, slipped 0.8% lower to $8.26 billion, falling shy of expectations for $8.28 billion.
While the numbers didn't exactly wow the Street (PEP shares are slightly lower in early trading), they also didn't illustrate a significant fall-off from the previous year, despite company warnings that the first half of 2009 would face challenging year-over-year comparisons amid rising commodity costs and shifting foreign exchange rates.
Continue reading PepsiCo Inc. (PEP) bids for bottlers as earnings edge lower
Posted Jan 28th 2009 12:19PM by Todd Harrison (RSS feed)
Filed under: Deals, Industry, Newmont Mining (NEM), Commodities
This post was written by Minyanville contributor Lance Lewis.
Just after the close yesterday, Newmont Mining (NYSE: NEM) guided up 2009 production and guided 2009 cash costs lower. NEM also announced that it would be purchasing the remaining interest in its majority owned Boddington Mine from Anglogold Ashanti (NYSE: AU) (which equates to 6.6 mln reserve ounces). That's an increase of 8 percent in NEM's Proven & Probable (P&P) reserves at a price tag of $1.2 bln, which will be raised via an equity offering of 19 mln shares.
Based on NEM's 441 mln shares outstanding, we're looking at dilution of just over 4 percent. Thus, in theory, the deal is not even dilutive, given the 8 percent increase in P&P reserves that the company is acquiring with only a 4 percent dilution in equity. Based on what I have seen so far, this looks like a spectacular deal for NEM.
Continue reading Newmont strikes a deal
Posted Jan 27th 2009 11:10AM by Tom Taulli (RSS feed)
Filed under: Deals, Law, Dow Chemical (DOW)
Back in July, Dow Chemical Co. (NYSE: DOW) agreed to pay $15.4 billion for Rohm & Haas Co. (NYSE: ROH), a top specialty chemicals operator. At the time, it looked like a sign that confidence was coming back into the system.
But, of course, the smart money was proved wrong – once again -- as the deal fell apart. So, this week Rohm & Haas has filed a suit against Dow to force the deal to happen. You see, the deal was supposed to close Monday.
The legal action rattled investors: On Monday, Dow's stock fell 7.61% to $13.24 and Rohm & Haas' stock was down 13.25% to $57.10.
Continue reading Dow Chemical's botched M&A experiment
Posted Jan 17th 2009 12:40PM by Sheldon Liber (RSS feed)
Filed under: Rants and raves, Competitive strategy, Microsoft (MSFT), Yahoo! (YHOO), Cisco Systems (CSCO), General Motors (GM), Sirius Satellite Radio (SIRI), Citigroup Inc. (C), Bank of America (BAC), Nucor Corp (NUE), Recession
Almost two years ago I posted a downbeat opinion about a merger that went through and one that did not. However the latter is being discussed again, unbelievable! SEE: GM/Chrysler or Sirius/XM: Two losers don't equal a winner.
In the story I rant about all the things that would improve General Motors (NYSE: GM) and where it is lacking -- noting that being bigger and having more models, less focus and more debt, are not among them. Eventually Cerberus made the big bet and lost. You can be sure they would like to play that hand over again.
Now all three U.S. car companies are in trouble with billions of dollars of losses and huge debt overhangs. All three begged for, and received some amount of federal relief and will need more to sustain themselves though 2009 as it proves to be every bit as tough as 2008 was. Despite everything, GM and Chrysler have been pondering a merger again. BAD IDEA! GM does not need the distraction, they need more focus -- nothing but intense focus!
Continue reading Mergers not heaven sent: Citi, GM, Chrysler, Sirius, AOL, Yahoo!, Microsoft
Posted Jan 14th 2009 11:05AM by Jamie Dlugosch (RSS feed)
Filed under: Deals, Employees, Genentech Inc (DNA)

After the initial rebuff of Swiss-based pharmaceutical giant Roche's offer to acquire the 44% of
Genentech (NYSE:
DNA) stock Roche does not currently own, DNA is coyly encouraging the completion of a deal at a higher price.
Genentech is among the leading biotech companies in the world. It is engaged in the discovery, development, manufacturing and commercialization of pharmaceutical products intended for treatment of previously untreatable illnesses.
In 1990, Roche acquired a 56% stake in the company. Since that time, the relationship between the two companies has been a model for similarly structured combinations.
Roche's offer of $89 per share for DNA was characterized by DNA as significantly undervaluing the company.
But this was hardly a "hit the road, Jack" response. DNA's board of directors has been encouraging the two sides to continue discussions, and recent comments suggest that the deal could come together soon.
Continue reading Don't sell your Genentech (DNA) stock just yet
Next Page >